Opinion

MedX Imaging LLC v. Texas Department of Health and Human Services

Court
District Court, N.D. Texas
Filed
Jul 27, 2025
Cited by
0 cases
Authority
More cited than 38.3%

The opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

FORT WORTH DIVISION

MEDX IMAGING LLC, ET AL., §

§

Plaintiffs, §

§

v. § Civil Action No. 4:24-CV-01259-O

§

TEXAS DEPARTMENT OF HEALTH §

AND HUMAN SERVICES, ET AL., §

§

Defendants. §

MEMORANDUM OPINION & ORDER

Before the Court are Defendants Texas Department of State Health Services (“DSHS”) and

its representative agents’ (collectively, “Defendants”) Second Motion to Dismiss and Brief in

Support (ECF No. 29), filed May 9, 2025; Plaintiffs MedX Imaging LLC d/b/a Eves Breast Center

(“MedX”) and Sarah Khan, M.D.’s (“Dr. Khan”) (collectively, “Plaintiffs”) Response (ECF

No. 30), filed May 16, 2025; Defendants’ Reply (ECF No. 31), filed May 30, 2025; and Plaintiffs’

Sur-reply (ECF No. 33), filed June 6, 2025. After examining the relative authorities and arguments,

the Court GRANTS Defendants’ Motion.

I. BACKGROUND1

Plaintiff MedX is a women’s imaging service center located in Southlake, Texas. It has

been owned and operated since 2011 by Dr. Khan, a board-certified radiologist with nearly

18 years of experience and fellowship training in mammography. Prior to the events giving rise to

1 Unless otherwise cited, the Court’s recitation of the facts is taken from Plaintiffs’ Amended Complaint

and the attached exhibits. See Pls.’ Am. Compl., ECF No. 26. When subject matter jurisdiction is challenged

on a Federal Rule of Civil Procedure 12(b)(1) facial attack, the facts alleged in the Complaint are presumed

to be true. Paterson v. Weinberger, 644 F.2d 521, 523 (5th Cir. 1981). The Court’s review is limited to

whether the Complaint is sufficient to allege jurisdiction. Id.

this suit, Dr. Khan began supervising Janis Lynn Wiscarson, a technologist who was required to

perform 25 supervised mammographic examinations before resuming independent performance

of mammography under Title 25 of the Texas Administrative Code Section 289.230(r)(2)(D).

On or around June 21, 2023, DSHS received a complaint alleging that Dr. Khan was

“positioning” during mammograms without the necessary prerequisites.2 DSHS investigated the

complaint by calling six MedX patients and performing a site inspection on July 20, 2023.

Plaintiffs allege that the inspection process was “highly intrusive and conducted in a manner that

was extremely disruptive to the clinic’s operations.”3

Specifically, Plaintiffs maintain Defendants advised technologists that they “should not

work for Dr. Khan,”4 that Dr. Khan was engaged in criminal wrongdoing, that Dr. Khan violated

regulatory standards, and that Dr. Khan’s career was “finished.”5 Plaintiffs allege Defendants’

“aggressive approach”6 led to the resignation of multiple employees of MedX, damaged MedX’s

reputation, made it difficult to retain or recruit new technologists, and resulted in the loss of

business opportunities.

DSHS eventually determined there was not enough evidence to substantiate the complaint

against Dr. Khan and closed its investigation. DSHS cited MedX for two violations, one of which

was under Section 289.230(r)(2)(D).7 The citation reads, “[t]he medical radiologic technologist

[Ms. Wiscarson] did not complete the required 25 supervised mammographic examinations for

2 See Defs.’ Br. Supp. Second Mot. to Dismiss 8, ECF No. 29-1.

3 Pls.’ Am. Compl. ¶ 29, ECF No. 26.

4 Id. ¶ 30.

5 Id. ¶ 52.

6 Id. ¶ 31.

7 Under Section 289.230(r)(2)(D), medical radiologic technologists who fail to meet continuing education

or experience requirements may re-establish their qualifications by performing 25 mammographic

examinations under the supervision of a qualified medical radiologic technologist. 25 TEX. ADMIN. CODE

§ 289.230(r)(2)(D).

requalification before resuming independent performance of mammography.”8 Since closing their

investigation, Defendants have not pursued further enforcement against Plaintiffs.9

Plaintiffs bring three causes of action, all seeking declaratory relief.10 First, Plaintiffs assert

that Defendants’ application of state mammography regulations to Dr. Khan violated her due

process rights.11 Second, Plaintiffs ask the Court to apply the Administrative Procedure Act’s

(“APA”) “arbitrary and capricious” standard to “inform the Court’s review of Plaintiffs’ federal

constitutional claims.”12 Third, Plaintiffs argue Defendants made “false and defamatory oral

statements regarding Dr. Khan’s conduct” that caused Plaintiffs to suffer “significant harm.”13

Defendants now move to dismiss Plaintiffs’ Amended Complaint under Federal Rule of

Civil Procedure 12(b)(1), or alternatively, under Rule 12(b)(6).

II. LEGAL STANDARD

Motions filed under Federal Rule of Civil Procedure 12(b)(1) allow a party to challenge

the subject matter jurisdiction of the district court to hear a case. FED. R. CIV. P. 12(b)(1). Because

a Rule 12(b)(1) motion concerns a court’s power to hear a case, when a Rule 12(b)(1) motion is

brought with other Rule 12 motions to dismiss, the Rule 12(b)(1) motion must be addressed first.

See Ramming v. United States, 281 F.3d 158, 161 (5th Cir. 2001).

There are two types of challenges to a court’s subject matter jurisdiction under

Rule 12(b)(1): a “facial attack” and a “factual attack.” See Paterson v. Weinberger, 644 F.2d 521,

523 (5th Cir. 1981). A facial attack challenges jurisdiction based solely on the pleadings. Id. When

8 Pls.’ Am. Compl. ¶ 19, ECF No. 26.

9 See Defs.’ Br. Supp. Second Mot. to Dismiss 8, ECF No. 29-1.

10 See Pls.’ Am. Compl. ¶¶ 32–35, ECF No. 26.

11 Id. ¶ ¶ 36–40.

12 Id. ¶ ¶ 41–48.

13 Id. ¶ ¶ 49–56.

ruling on a facial attack, a court must presume that factual allegations in the complaint are true and

determine whether they establish subject matter jurisdiction. Id. The burden of proof for a

Rule 12(b)(1) motion is “on the party asserting jurisdiction . . . the plaintiff constantly bears the

burden of proof that jurisdiction does in fact exist.” Ramming, 281 F.3d at 161.

III. ANALYSIS

In their Amended Complaint, Plaintiffs bring three causes of action: (1) violations of

Plaintiffs’ rights to due process under the Fifth and Fourteenth Amendments; (2) a request for the

Court to apply the “arbitrary and capricious” standard of the APA, 5 U.S.C. § 706(2)(A), in

reviewing Plaintiffs’ constitutional claims; and (3) defamation.14 Defendants now move to dismiss

each claim under Rule 12(b)(1).15 Alternatively, Defendants move to dismiss Plaintiffs’ due

process claim and request for application of the “arbitrary and capricious” standard under

Rule 12(b)(6) for failure to state a claim.16

The Court determines that, at this stage of litigation, Plaintiffs have failed to demonstrate17

the Court has subject matter jurisdiction with respect to any of their claims because: (1) Plaintiffs

lack standing to sue for declaratory relief under their due process claim and request for the Court

to apply the “arbitrary and capricious” standard, and (2) Plaintiffs’ defamation claims are barred

by Eleventh Amendment immunity. Because the Court lacks jurisdiction over Plaintiffs’ claims,

the Court does not reach the merits of Defendants’ Rule 12(b)(6) arguments.

A. Standing

The Court begins with Plaintiffs’ due process claim and request for the Court to apply the

“arbitrary and capricious” standard. Although Defendants argue that Plaintiffs’ due process claim

14 See Pls.’ Am. Compl. ¶¶ 36–56, ECF No. 26.

15 See Defs.’ Br. Supp. Second Mot. to Dismiss 8–13, ECF No. 29-1.

16 Id. at 16–18.

17 See Ramming, 281 F.3d at 161.

is not ripe for adjudication,18 the Court addresses this argument under a standing analysis.19

Article III of the Constitution limits the exercise of the judicial power to “Cases” and

“Controversies.” U.S. CONST. art. III, § 2, cl. 1. The “core component of standing is an essential

and unchanging part of the case-or-controversy requirement of Article III.” Lujan v. Defs. of

Wildlife, 504 U.S. 555, 560 (1992). So, for this Court to hear their case, Plaintiffs must demonstrate

that they have standing. Moreover, they must show standing separately for each claim and each

form of relief sought. In re Latitude Sols., Inc., 922 F.3d 690, 695 (5th Cir. 2019).

There are ordinarily three requirements for Article III standing. A party seeking relief in

federal court must demonstrate: (1) an “injury-in-fact,” which is “concrete and particularized” and

“actual or imminent, not conjectural or hypothetical”; (2) the injury is “fairly traceable to the

challenged action”; and (3) it is “likely . . . that the injury will be redressed by a

favorable decision.” Lujan, 504 U.S. at 560–61 (citation modified). “[E]ach element must be

supported in the same way as any other matter on which the plaintiff bears the burden of proof,

i.e., with the manner and degree of evidence required at the successive stages of the litigation.” Id.

at 561.

To establish Article III standing when seeking injunctive or declaratory relief, “a plaintiff

must allege facts from which it appears there is a substantial likelihood that he will suffer injury

in the future.” Bauer v. Texas, 341 F.3d 352, 358 (5th Cir. 2003). Specifically, “a plaintiff must

demonstrate either continuing harm or a real and immediate threat of repeated injury in the future.”

Id. The Court addresses each in turn.

18 See Defs.’ Br. Supp. Second Mot. to Dismiss 14–15, ECF No. 29-1; Defs.’ Reply 4–5, ECF No. 31.

19 Standing and ripeness both “originate from the same Article III limitation” and “boil down to the same

question.” Susan B. Anthony List v. Driehaus, 573 U.S. 149, 157 n.5 (2014) (internal quotation marks and

citation omitted).

1. Plaintiffs are not suffering any continuing, present adverse effects from

Defendants’ past conduct.

Plaintiffs may establish Article III standing by demonstrating continuing harm caused by

Defendants’ past actions. Bauer, 341 F.3d at 358. Plaintiffs’ due process claim and request for

application of the “arbitrary and capricious” standard are based on Defendants’ alleged application

of Section 289.230(r)(2) to Dr. Khan.20

In her due process claim, Dr. Khan asserts that DSHS’s “application of rules” concerning

mammography is “arbitrary and capricious” and infringes on Dr. Khan’s “right to perform and

interpret mammograms.”21 In their request for the Court to use the “arbitrary and capricious”

standard, Plaintiffs allege that “Defendants have engaged in arbitrary and capricious conduct by

its erroneous application of [Section 289.230(r)(2)] according to [Section 601.151].”22 Plaintiffs,

though, fail to present evidence that would allow the Court to conclude that Section 289.230(r)(2)

is being applied to Dr. Khan at all. The Court accordingly disagrees with Plaintiffs; Dr. Khan is

not suffering continuous harm by Defendants’ past actions.

On or around June 21, 2023, an anonymous complainant alleged that Dr. Khan was

“engaged in positioning during mammograms without the required prerequisites needed to perform

mammograms.”23 DSHS investigated, determined that the complaint was unsubstantiated, and

closed the investigation.24 Though DSHS cited MedX for violations of Section 289.230(r)(2),

Defendants argue that this “[v]iolation was specific to the technologist Ms. Wiscarson’s activities

20 Though Plaintiffs argue that Defendants are “restricting both MedX and Dr. Khan” without due process,

their due process claim and request for application of the “arbitrary and capricious standard” focus only on

the application of Section 289.230(r)(2) to Dr Khan, not MedX. Cf. Pls.’ Am. Compl. ¶¶ 36, 46–47, ECF

No. 26. Accordingly, the Court’s analysis focuses on whether Dr. Khan is suffering continuous harm.

21 See Pls.’ Am. Compl. ¶ 39, ECF No. 26.

22 Id. ¶ 45.

23 Defs.’ Br. Supp. Second Mot. to Dismiss 8, ECF No. 29-1.

24 See Pls.’ Am. Compl. ¶¶ 28–31, ECF No. 26; Pls.’ Am. Compl. Ex. E (“Exhibit E”), at 26–32, ECF

No. 26.

and not Dr. Khan’s activities.”25 Plaintiffs do not refute this; nor do they argue that DSHS

erroneously cited Ms. Wiscarson for violating Section 289.230(r)(2).

There is no evidence on the record to support Plaintiffs’ assertion that Defendants are

applying Section 289.230(r)(2) to Dr. Khan, much less in a manner that (1) violates her due process

rights or (2) is arbitrary and capricious. Plaintiffs argue that the injury to them is “live and

determinable upon the Defendant[s’] stance of [Dr. Khan’s] compliance.”26 This does not

demonstrate current injury, however, only the possibility of a future injury “upon” a contingent

event.27 Thus, Plaintiffs are not suffering continuing, present adverse effects from Defendants’ past

actions.

2. There is not a substantial likelihood that Plaintiffs will suffer injury in the

future.

In the absence of continuing harm from a defendant’s past conduct, a plaintiff seeking

declaratory relief must “allege facts from which it appears there is a substantial likelihood that he

will suffer injury in the future.” Bauer, 341 F.3d at 358. Plaintiffs have failed to plead facts that

would allow the Court to find such a likelihood here. Plaintiffs admit that Defendants’ investigation

was “ultimately closed without any finding of wrongdoing.”28 Since then, Defendants have not

pursued further enforcement against Plaintiffs.29

Plaintiffs argue that “[e]ven if there is no current investigation or enforcement, [Dr. Khan]

still faces injury due to the threat of future enforcement,”30 and that under the ripeness doctrine,

they need not “endure enforcement before seeking relief.”31 The Court acknowledges that

25 See Defs.’ Br. Supp. Second Mot. to Dismiss 8, ECF No. 29-1.

26 Pls.’ Sur-reply 2, ECF No. 33.

27 Id. at 2.

28 Id. at 3.

29 See Defs.’ Br. Supp. Second Mot. to Dismiss 8, ECF No. 29-1.

30 Pl.’s Sur-reply 3, ECF No 33.

31 Id.

Plaintiffs’ arguments are centered on ripeness, not standing. Nevertheless, the cases cited by

Plaintiffs for their ripeness arguments still demand there be a “credible threat of prosecution” for

Plaintiffs to satisfy Article III’s injury-in-fact requirement. Susan B. Anthony List v. Driehaus, 573

U.S. 149, 158–59 (2014). Comparisons between this suit and those cases in which the plaintiff

faced a “credible threat of prosecution” demonstrate that Plaintiffs here do not face a “substantial

likelihood” of future injury as required under Bauer. 341 F.3d at 358.

In Susan B. Anthony List, the Supreme Court held that a plaintiff satisfies Article III’s

injury-in-fact requirement “where he alleges ‘an intention to engage in a course of conduct

arguably affected with a constitutional interest, but proscribed by a statute, and there exists a

credible threat of prosecution thereunder.’” 573 U.S. at 159 (emphasis added) (quoting Babbitt v.

Farm Workers, 442 U.S. 289, 298 (1979)). In Susan B. Anthony List, the plaintiff had already been

subject to past enforcement of the challenged law, and the Ohio Election Commission found

“probable cause to believe that SBA violated the statute.” Id. at 162. Here, Defendants have already

investigated Plaintiffs and found the complaint against them unsubstantiated.32 Since then,

Defendants have given Plaintiffs no indication of any intention to investigate them in the future.

Plaintiffs, in fact, admit that Dr. Khan “now has the certifications that technicians have and meets

all the criteria of a radiology technician,”33 thereby further extinguishing any threat of future injury

from DSHS regarding enforcement of Section 289.230(r)(2).

Plaintiffs next cite Abbott Laboratories v. Gardner to argue that the Supreme Court

“permitted pre-enforcement judicial review where a regulation imposed immediate and significant

burdens and waiting for enforcement would cause substantial hardship.”34 387 U.S. 136, 149

32 See Exhibit E, at 34, ECF No. 26.

33 Pls.’ Resp. 3, ECF No. 30.

34 Pls.’ Sur-reply 4, ECF No. 33.

(1967). By saying “[t]hat principle applies directly here,” Plaintiffs draw a comparison between

Section 289.230(r)(2) and the regulation in Abbott Laboratories. The regulation at issue in that

case was “promulgated in a formal manner after announcement in the Federal Register and

consideration of comments.” Id. at 151. This was an agency action, a “statement of general or

particular applicability and future effect designed to implement, interpret, or prescribe law or

policy.” Id. at 149. Here, DSHS made no statements about the applicability of

Section 289.230(r)(2) to Dr. Khan. To the contrary, its investigation ended in a finding that the

complaint was unsubstantiated.35

Finally, Plaintiffs cite MedImmune, Inc. v. Genentech, Inc. to argue that “a party need not

break the law or wait for enforcement to seek relief when the threat of penalties hangs over their

head.”36 549 U.S. 118, 127 (2007). The Supreme Court, though, explained its holding applied

where there was a “genuine threat of enforcement.” Id. at 129. The plaintiffs in MedImmune, Inc.

had avoided an “imminent threat of harm” only by being “effectively coerced” from pursuing

activities they claimed to have a legal right to do. Id. There is no such coercion or genuine threat

of enforcement in this case. DSHS received a complaint of wrongdoing, investigated the

complaint, and ultimately determined the complaint was unsubstantiated. DSHS has since taken

no actions to indicate any future enforcement.37

Because Plaintiffs have failed to demonstrate (1) continuing, present adverse effects from

past illegal conduct, or (2) a substantial likelihood of future injury, Plaintiffs lack standing to bring

their due process claim and request for application of the “arbitrary and capricious” standard. See

Bauer, 341 F.3d at 358. Accordingly, the Court DISMISSES these claims.

35 See id. at 3.

36 Id. at 4.

37 See Defs.’ Br. Supp. Second Mot. to Dismiss 8, ECF No. 29-1.

B. Eleventh Amendment Immunity

In their Amended Complaint, Plaintiffs also bring defamation claims against Defendants

for both slander and libel.38 Specifically, they allege that Defendants “[m]ade false and defamatory

oral statements regarding Dr. Khan’s conduct, including but not limited to accusing her of

‘criminal’ wrongdoing, suggesting she was unqualified or in violation of regulatory standards, and

asserting that her career was ‘finished.’”39 They also contend that as a result of the alleged

defamation, Plaintiffs suffered “damage to Dr. Khan’s reputation,” “loss of current and prospective

business opportunities,” and “financial harm,” among other injuries.40

Defendants argue that “Eleventh Amendment immunity applies to defamation claims if

there is no showing of a waiver or abrogation of immunity” and that Plaintiffs have failed to show

“or even allege any waiver or abrogation.”41 Plaintiffs, in turn, argue that their defamation claims

fall under the Ex parte Young exception.42 The Court agrees with Defendants.

The Fifth Circuit in Green Valley Special Utilility District v. City of Schertz stated that for

Ex parte Young to apply, three criteria must be met: “(1) [a] plaintiff must name individual state

officials as defendants in their official capacities; (2) the plaintiff must allege an ongoing violation

of federal law; and (3) the relief sought must be properly characterized as prospective.” 969 F.3d

460, 471 (5th Cir. 2020) (emphasis added) (citation modified). Courts are to conduct a

“straightforward inquiry” and avoid evaluating the merits of the underlying claims. Id. (citation

omitted).

38 See Pls.’ Am. Compl. ¶¶ 49–56, ECF No. 26.

39 Id. ¶ 52.

40 Id. ¶ 56.

41 Defs.’ Br. Supp. Second Mot. to Dismiss 13, ECF No. 29-1.

42 Pls. Resp. 8–9, ECF No. 30.

The Court holds that Plaintiffs have not sought prospective relief. The Fifth Circuit has

held that “[uJnder Ex parte Young, a court is permitted to command|] a state official to do nothing

more than refrain from violating federal law.” Jackson v. Wright, 82 F.4th 362, 368 (Sth Cir. 2023)

(second alteration in original) (internal quotation marks and citation omitted). Indeed, the Ex parte

Young exception “does not permit judgments against state officers declaring that they violated

federal law in the past.” /d. (citation omitted).

In their Prayer for Relief, Plaintiffs ask the Court to “[d]eclare the Defendants’ statements

and actions as defamatory.’ Plaintiffs maintain, however, that Defendants’ defamatory statements

were made “during the investigation of MedX and Dr. Khan.’ Plaintiffs have failed to allege that

Defendants have continued to make defamatory statements since then. Any declaratory relief from

the Court would thus focus on Defendants’ past conduct, constitute retrospective relief, and be

barred by Eleventh Amendment immunity. Accordingly, the Court must DISMISS Plaintiffs’

defamation claims because Plaintiffs do not seek prospective relief to invoke the Ex parte Young

exception.

IV. CONCLUSION

For the foregoing reasons, the Court GRANTS Defendants’ Second Motion to Dismiss

(ECF No. 29). Accordingly, Plaintiffs’ claims are hereby DISMISSED without prejudice.

Separate final judgment shall issue.

SO ORDERED on this 27th day of July, 2025.

UNITED STATES DISTRICT JUDGE

‘3 Pls.” Am. Compl. 957, ECF No. 26.

“4 Id. 454.

11

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.